Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00428181 · ClinicalTrials.gov registry record · Phase 3
Multidisciplinary Approach to Reduce Injury and Alcohol
A Phase 3 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 3
- Development phase
- 605
- Enrollment target
NCT00428181: Completed Phase 3 study, sponsored by University of Texas at Austin.
NCT00428181 is a Phase 3 study that has completed, run by University of Texas at Austin. The registered enrollment target is 605 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00428181, a Phase 3 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 605 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a booster session is needed after a brief intervention upon initial admission to the emergency room (ER) in order to reduce the rate of alcohol-related injury recidivism.
Interventions
- BEHAVIORAL Brief alcohol intervention
- BEHAVIORAL Brief alcohol intervention plus booster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 605 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-10 |
| Phase | Phase 3 |
What the finished NCT00428181 record still lists
NCT00428181 is an interventional study that assigns participants to a tested intervention. The registered 605 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 2 interventions - of which Brief alcohol intervention is the first listed.
NCT00428181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00428181 about?
NCT00428181 is a clinical study titled "Multidisciplinary Approach to Reduce Injury and Alcohol". The purpose of this study is to determine whether a booster session is needed after a brief intervention upon initial admission to the emergency room (ER) in order to reduce the rate of alcohol-related injury recidivism.
What is the current status of trial NCT00428181?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 605 participants. The study started on 2007-09. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00428181?
The interventions under investigation include: Brief alcohol intervention (BEHAVIORAL), Brief alcohol intervention plus booster (BEHAVIORAL).
Who is sponsoring clinical trial NCT00428181?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00428181's enrollment target sits among peer trials
605 607th of 2000 higher than 1,394 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia